Zhu, Kanger <br/><br/>
Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review.  [electronic resource] 

 -  Hematology (Amsterdam, Netherlands)  Oct 2005 
 - 365-70 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1024-5332 
<br/><br/><label>Standard No.: </label>10.1080/10245330410001714202  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ABO Blood-Group System<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Child, Preschool<br/>Cord Blood Stem Cell Transplantation--methods<br/>Epstein-Barr Virus Infections--drug therapy<br/>Female<br/>Histocompatibility Testing<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--complications<br/>Lymphoproliferative Disorders--drug therapy<br/>Red-Cell Aplasia, Pure--drug therapy<br/>Rituximab